RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
-3.83%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$928M
AUM Growth
+$928M
(-2.2%)
Cap. Flow
+$42.1M
Cap. Flow
% of AUM
4.54%
Top 10 Holdings %
Top 10 Hldgs %
34.27%
Holding
87
New
4
Increased
25
Reduced
17
Closed
2
Top Buys
| 1 |
Eli Lilly
LLY
|
$10.2M |
| 2 |
Charles River Laboratories
CRL
|
$8.62M |
| 3 |
Procept Biorobotics
PRCT
|
$7.02M |
| 4 |
Intuitive Surgical
ISRG
|
$6.87M |
| 5 |
Medtronic
MDT
|
$6.5M |
Top Sells
| 1 |
Cigna
CI
|
$10M |
| 2 |
Zimmer Biomet
ZBH
|
$8.75M |
| 3 |
Elevance Health
ELV
|
$7.84M |
| 4 |
UnitedHealth
UNH
|
$7.06M |
| 5 |
Molina Healthcare
MOH
|
$6.54M |
Sector Composition
| 1 | Healthcare | 99.51% |
| 2 | Industrials | 0.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Immunocore
IMCR
$1.78B
| $4.63M | 0.5% |
89,278
| – | – |
|
52
Xencor
XNCR
$594M
| $4.53M | 0.49% |
225,000
| – | – |
|
|
RCM
53
DELISTED
R1 RCM Inc. Common Stock
RCM
| $4.52M | 0.49% |
300,000
| – | – |
|
54
Iovance Biotherapeutics
IOVA
$800M
| $4.32M | 0.47% |
950,000
+100,000
| +12% | +$455K |
|
55
Oscar Health
OSCR
$4.57B
| $4.29M | 0.46% |
+770,000
| New | +$4.29M |
|
56
DexCom
DXCM
$30.9B
| $4.2M | 0.45% |
+45,000
| New | +$4.2M |
|
|
RVNC
57
DELISTED
Revance Therapeutics, Inc.
RVNC
| $4.15M | 0.45% |
361,679
+238,679
| +194% | +$2.74M |
|
58
Royalty Pharma
RPRX
$15.8B
| $4.07M | 0.44% |
150,000
| – | – |
|
59
Nuvalent
NUVL
$5.74B
| $3.95M | 0.43% |
86,011
| – | – |
|
60
Evolent Health
EVH
$1.11B
| $3.95M | 0.43% |
145,000
| – | – |
|
61
BridgeBio Pharma
BBIO
$9.91B
| $3.56M | 0.38% |
135,000
| – | – |
|
62
West Pharmaceutical
WST
$17.9B
| $3.38M | 0.36% |
9,000
| – | – |
|
63
Health Catalyst
HCAT
$228M
| $3.24M | 0.35% |
320,000
| – | – |
|
64
Moderna
MRNA
$9.36B
| $3.1M | 0.33% |
30,000
-15,000
| -33% | -$1.55M |
|
65
Bio-Techne
TECH
$8.3B
| $2.91M | 0.31% |
42,680
-4,820
| -10% | -$328K |
|
66
10x Genomics
TXG
$1.66B
| $2.81M | 0.3% |
68,000
-68,000
| -50% | -$2.81M |
|
67
Axsome Therapeutics
AXSM
$6.09B
| $2.8M | 0.3% |
40,100
| – | – |
|
68
Harmony Biosciences
HRMY
$2.16B
| $2.67M | 0.29% |
81,474
-128,526
| -61% | -$4.21M |
|
69
MeiraGTx Holdings
MGTX
$590M
| $2.65M | 0.29% |
538,986
| – | – |
|
|
OLK
70
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $2.45M | 0.26% |
166,000
| – | – |
|
71
Centene
CNC
$14.8B
| $2.07M | 0.22% |
+30,000
| New | +$2.07M |
|
72
Edwards Lifesciences
EW
$47.7B
| $2.01M | 0.22% |
29,000
| – | – |
|
73
Viking Therapeutics
VKTX
$3.02B
| $1.99M | 0.21% |
180,000
| – | – |
|
|
IGMS
74
DELISTED
IGM Biosciences
IGMS
| $1.67M | 0.18% |
200,000
| – | – |
|
75
Arvinas
ARVN
$580M
| $1.67M | 0.18% |
85,000
| – | – |
|